Abstract: A semiconductor memory device includes a memory cell array, an error correction circuit, an error log register and a control logic circuit. The memory cell array includes a plurality of memory bank arrays and each of the memory bank arrays includes a plurality of pages. The control logic circuit is configured to control the error correction circuit to perform an ECC decoding sequentially on some of the pages designated at least one access address for detecting at least one bit error, in response to a first command received from a memory controller. The control logic circuit performs an error logging operation to write page error information into the error log register and the page error information includes a number of error occurrence on each of the some pages determined from the detecting.

Abstract: The present invention provides: a recombinant expression vector comprising a gene encoding a porcine parvovirus VP2 protein; a recombinant plant or a recombinant insect cell transformed with the vector; and a vaccine composition for a porcine parvovirus and a composition for diagnosing porcine parvovirus, both of which contain a porcine parvovirus VP2 protein obtained from the recombinant plant or the recombinant insect cell. When the recombinant plant or recombinant insect cell of the present invention is used, the porcine parvovirus antigenic protein can be produced with high efficiency, and the porcine parvovirus antigenic protein production method using the recombinant plant or recombinant insect cell has excellent safety and stability compared with other antigen production methods.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating CMT disease, comprising histone deacetylase 6 inhibitor. The pharmaceutical composition according to the present invention has histone deacetylase 6 (HDAC6) inhibitory activity and thus is effective in preventing or treating CMT disease.

Abstract: A control valve and a variable capacity compressor having a control valve or a passage connecting the control valve and a crank chamber. A fixed orifice hole is variable which is possible by selectively opening and closing a plurality of holes depending on the operation of the compressor.

Abstract: A method for measuring displacements of an end effector passing through a load lock gate of semiconductor equipment according to an embodiment of the present disclosure includes measuring a first displacement in a vertical direction and a second displacement in a horizontal direction of the end effector while the end effector passes through the load lock gate, calculating changes in pitch and roll of the end effector based on the measured first displacement, and calculating a change in yaw of the end effector based on the measured second displacement.

Abstract: A method for determining the status of a robot according to an embodiment includes acquiring first data and second data related to an operation of the robot, acquiring a resonance frequency by analyzing the operation of the robot in a frequency region based on the first data related to the operation of the robot, acquiring a first comparison result by comparing the acquired resonance frequency with a reference resonance frequency, when the first comparison result is a threshold value or more, generating a Lissajous figure by DQ transforming a three-phase signal based on the second data related to the operation of the robot, acquiring a second comparison result by comparing the generated Lissajous figure with a reference Lissajous figure, and determining the status of the robot based on at least one of the first comparison result and the second comparison result.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating cancer, a radiosensitizer composition for treating cancer, and a health functional food for preventing or improving cancer, which comprise N-1H-benzimidazol-2-yl-3-(1H-pyrrol-1-yl) benzamide, a derivative thereof, or a pharmaceutically acceptable salt thereof as an active ingredient. The pharmaceutical composition comprising N-1H-benzimidazol-2-yl-3-(1H-pyrrol-1-yl) benzamide or a derivative thereof as an active ingredient according to the present invention arrests the mitosis of cancer cells to prevent proliferation and at the same time, to exhibit low toxicity in normal cell lines and induce apoptosis only in cancer cell lines, so it can be used as an effective anticancer agent. In addition, the N-1H-benzimidazol-2-yl-3-(1H-pyrrol-1-yl) benzamide of the present invention can increase the sensitivity of the treated cancer cells to radiation, so it can be used as a radiosensitizer composition for cancer treatment.

Abstract: A display device includes a touch panel (TP), a transparent adhesive member (TAM) on a surface of the TP, a touch printed circuit board (TPCB), and a display panel (DP) on a surface of the TAM. The TP includes a sensing portion and a pad side portion (PSP) on a side of the sensing portion. The TPCB includes a contact portion (CP) attached to a surface of the PSP. The DP includes a substrate, an optical film (OF) on a surface of the substrate, and a bending protection layer (BPL) on a side of the OF on the surface of the substrate. The surface of the PSP includes a connection area attached to the CP and a non-connection area not attached to the CP. The OF is spaced from the BPL with a gap disposed therebetween. The TAM overlaps, in a thickness direction, with the TPCB and the gap.

Abstract: Melanophilin (MLPH) of the present invention is involved in differentiation into an adipocyte or fat accumulation, and accordingly, obesity can be treated or prevented by inhibiting the MLPH. Further, by measuring an expression level of the MLPH, obesity can be diagnosed and treated, and therapeutic agents for obesity and agents regulating differentiation into adipocytes can be screened.

Abstract: A fusion protein containing a biologically active protein and an FGF21 mutant protein, a pharmaceutical composition containing the fusion protein, and their uses are disclosed. The fusion protein and the pharmaceutical composition are effective in treating a liver disease including hepatitis, hepatic fibrosis, and hepatic cirrhosis. The fusion protein has effects of inhibiting proliferation of inflammatory cells and fibroblasts, and thus can be effectively used for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis.

Abstract: A sphere-type shift control apparatus for an electronic transmission system includes a shift operation unit configured to be operated by a driver of a vehicle for gear shifting on a first hemisphere of a spherical mechanism and a design unit for indirect illumination and image transmission on a second hemisphere of the spherical mechanism. By rotating the spherical mechanism, only the shift operation unit is exposed to a vehicle interior through an opening of a housing when a shift operation is required, while only the design unit is exposed to the vehicle interior through the opening of the housing when the shift operation is not required.

Abstract: The present invention relates to antibody-drug conjugates (ADCs) wherein a plurality of active agents are conjugated to an antibody through at least one branched linker. The branched linker may comprise a branching unit, and two active agents are coupled to the branching unit through a secondary linker and the branching unit is coupled to the antibody by a primary linker. The active agents may be the same or different. In certain such embodiments, two or more such branched linkers are conjugated to the antibody, e.g., 2-4 branched linkers, which may each be coupled to a different C-terminal cysteine of a heavy or light chain of the antibody. The branched linker may comprise one active agent coupled to the branching unit by a first branch and a second branch that comprises a polyethylene glycol moiety coupled to the branching unit. In certain such embodiments, two or more such branched linkers are conjugated to the antibody, e.g.

Abstract: The present invention provides a thiophene carboxamide compound of the following General Formula (I), which is a novel fluorine-substituted biphenyl carboxamide-based compound, and provides a useful compound, as an agricultural and horticultural plant disease control agent, exhibiting an excellent control effect at a low dose. wherein, R, R1, R2, R3, Xm, and Y are each as defined in the specification.

Abstract: In some aspects, the invention relates to an antibody-drug conjugate, comprising an antibody; a linker; and at least two active agents. In preferred embodiments, the linker comprises a peptide sequence of a plurality of amino acids, and at least two of the active agents are covalently coupled to side chains of the amino acids. The antibody-drug conjugate may comprise a self-immolative group, preferably two-self-immolative groups. The linker may comprise an O-substituted oxime, e.g., wherein the oxygen atom of the oxime is substituted with a group that covalently links the oxime to the active agent; and the carbon atom of the oxime is substituted with a group that covalently links the oxime to the antibody.

Abstract: A memory module includes a memory device, a command/address buffering device, and a processing data buffer. The memory device includes a memory cell array, a first set of input/output terminals, each terminal configured to receive first command/address bits, and a second set of input/output terminals, each terminal configured to receive both data bits and second command/address bits. The command/address buffering device is configured to output the first command/address bits to the first set of input/output terminals. The processing data buffer is configured to output the data bits and second command/address bits to the second set of input/output terminals. The memory device is configured such that the first command/address bits, second command/address bits, and data bits are all used to access the memory cell array.

Abstract: The present invention relates to a device for measuring the thermal characteristics of a pouch-type battery cell, specifically, the thermal conductivity of the battery cell, and a thermal conductivity measurement method using the same. When the battery cell thermal conductivity measurement device of the present invention is used, the thermal conductivity of a pouch-type battery cell exhibiting anisotropic thermal conductivity characteristics can be separated along each direction and measured, and thereby stability according to the thermal characteristics of a product, which uses a battery cell for a rechargeable battery, can be efficiently evaluated.

Abstract: A display device includes: a first substrate including a display area and a pad area; a second substrate facing the first substrate, a touch portion on the second substrate, a first flexible circuit board coupled to the first substrate, a second flexible circuit board coupled to the touch portion, a first adhesive layer on the first flexible circuit board, and a second adhesive layer that attaches the first adhesive layer and the second flexible circuit board to each other. The first adhesive layer and the second adhesive layer are formed of different materials from each other.

Abstract: A dial type shift control apparatus for an electronic shift system is provided. The dial type shift control apparatus includes a main housing having a boss portion protruding upward, a bearing fitted to an outside of the boss portion, a rotator fitted to an outside of the bearing, and a shift dial coupled to the rotator. The shift dial covers the rotator and the bearing from above, and the shift dial is configured to rotate with the rotator when operated by a driver.

Abstract: The disclosure relates to an apparatus for lifting a movable base of a toilet, and more particularly to an apparatus for lifting a movable base of a toilet, which can simplify a structure and assist a toilet user in safely standing up by making the movable base where the toilet user sits be automatically movable with a simple structure, be driven to have lifting movement and pivoting movement, and be structured to minutely generate the pivoting movement, and which can quickly deal with emergency situations of a user by making an alarm go off in the emergency situations and transmitting information about the emergency situations to at least one previously set terminal.

Abstract: Disclosed is a method for eliminating odors including administering a deodorant composition containing an Opuntia ficus (prickly pear) extract or a fraction thereof as an active ingredient. The deodorant composition, which further contains a persimmon extract or a fraction thereof, a persimmon juice, or a green tea extract or a fraction thereof, is useful as a deodorizer for removing or reducing ammonia and trimethylamine.